Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
127201000087110 | quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion (médicament clinique) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
322431000077110 | quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
3689931015 | Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3689933017 | Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | est un(e) (attribut) | Product containing only dalfopristin and quinupristin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | est un(e) (attribut) | médicament contenant quinupristine et dalfopristine | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | a pour principe actif (attribut) | Quinupristin (substance) | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | a pour principe actif (attribut) | Dalfopristin (substance) | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | a une forme pharmaceutique (attribut) | Powder for infusion solution | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | a une forme pharmaceutique (attribut) | Powder for solution for injection | true | Inferred relationship | Some | ||
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength numerator value (attribute) | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has basis of strength substance (attribute) | Dalfopristin (substance) | true | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has presentation strength numerator value (attribute) | 350 (qualifier value) | false | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has precise active ingredient | dalfopristine mésilate | true | Inferred relationship | Some | 2 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has precise active ingredient | Quinupristin mesilate | true | Inferred relationship | Some | 1 | |
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion | Has basis of strength substance (attribute) | Quinupristin (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets